Hematological Alterations in Patients with COVID-19

Dania María García Rodríguez, Dionis Ruiz Reyes, Madyaret Águila Carbelo, Adriel Herrero Díaz and Ileana Beatriz Quiroga López

SAP Health and Policy, 2025

Abstract: Currently, the global population is under siege from COVID-19, a disease caused by the SARS-CoV-2 coronavirus, which has been declared a pandemic by the World Health Organization. COVID-19 usually presents with mild respiratory symptoms but is also associated with less common and somewhat delayed clinical manifestations such as thrombotic events (arterial or venous), skin inflammation, vasculitis, and the development of pulmonary fibrosis.A literature review was conducted with the aim of characterizing hematological changes in patients during COVID-19. A total of 23 bibliographic references were reviewed, including books, journals, and websites from the Scielo and Infomed platforms.It was found that the main hematological alterations caused by COVID-19 include lymphocytopenia, increased D-dimer, thrombocytopenia, platelet deficiency, and thrombosis, all of which are favored by the cytokine storm.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://southam.pub/journals/files/shp/shp2025242en.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cwf:shpart:shp2025242

DOI: 10.56294/shp2025242

Access Statistics for this article

More articles in SAP Health and Policy from South American Publishing
Bibliographic data for series maintained by South American Publishing Journals Manager ().